Cargando…
Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data
BACKGROUND/PURPOSE: Expert guidelines specify no upper age limit for alteplase for thrombolysis of acute ischemic stroke (AIS) but, until recently, European regulatory criteria restricted its use to patients aged 18 to 80 years. We performed pooled analyses of randomized controlled trial (RCT) and r...
Autores principales: | Bluhmki, Erich, Danays, Thierry, Biegert, Gabriele, Hacke, Werner, Lees, Kennedy R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382542/ https://www.ncbi.nlm.nih.gov/pubmed/32611284 http://dx.doi.org/10.1161/STROKEAHA.119.028396 |
Ejemplares similares
-
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
por: Emberson, Jonathan, et al.
Publicado: (2014) -
Effects of alteplase in the treatment of acute ischemic stroke
por: Yayan, Josef
Publicado: (2012) -
Safety and efficacy of alteplase in the treatment of acute ischemic stroke
por: Micieli, Giuseppe, et al.
Publicado: (2009) -
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022) -
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
por: Koga, Masatoshi, et al.
Publicado: (2020)